Breaking News Instant updates and real-time market news.

BWXT

BWX Technologies

$60.85

0.68 (1.13%)

16:31
11/06/18
11/06
16:31
11/06/18
16:31

BWX Technologies reports Q3 adjusted EPS 40c, consensus 62c

Reports Q3 revenue $426M, consensus $461.09M.

  • 07

    Nov

BWXT BWX Technologies
$60.85

0.68 (1.13%)

05/22/18
FBCO
05/22/18
NO CHANGE
Target $64
FBCO
Neutral
BWX Technologies price target lowered to $64 from $72 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for BWX Technologies to $64 from $72 as he downgrades his outlook for Defense hardware stocks to neutral from bullish. The analyst reiterates a Neutral rating on the shares.
05/24/18
BOFA
05/24/18
DOWNGRADE
BOFA
Neutral
BWX Technologies downgraded to Neutral from Buy at BofA/Merrill
05/24/18
05/24/18
DOWNGRADE
Target $70

Neutral
BWX Technologies downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded BWX Technologies to Neutral from Buy. Analyst Ronald Epstein said valuation reflects US Navy and medical radioisotopes growth and maintained a $70 price target on shares.
06/18/18
JEFF
06/18/18
NO CHANGE
Target $21
JEFF
Buy
Lantheus position in moly more secure than stock suggests, says Jefferies
A presentation by new molybdenum-99 supplier SHINE Medical Technologies adds more support to Lantheus' (LNTH) position in the market being more secure than the current stock price reflects, Jefferies analyst Raj Denhoy tells investors in a research note. SHINE expects to bring production online in 2021, with Lantheus already contracted to use its molybdenum-99, the analyst adds. He believes the market is "vastly overestimating" the threat from new entrants and "vastly underappreciating" the company's "hold on this market." Denhoy sees little chance of BWX Technologies (BWXT) gaining significant traction given the manufacturing and regulatory challenges in bringing a generator to market. He keeps a Buy rating on Lantheus with a $21 price target.

TODAY'S FREE FLY STORIES

ZAYO

Zayo Group

$24.05

1.54 (6.84%)

07:01
11/14/18
11/14
07:01
11/14/18
07:01
Recommendations
Zayo Group analyst commentary  »

Zayo Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HD

Home Depot

06:59
11/14/18
11/14
06:59
11/14/18
06:59
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$78.90

0.04 (0.05%)

06:59
11/14/18
11/14
06:59
11/14/18
06:59
Recommendations
NetApp analyst commentary  »

NetApp positioned as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AAP

Advance Auto Parts

$184.66

17.72 (10.61%)

06:58
11/14/18
11/14
06:58
11/14/18
06:58
Recommendations
Advance Auto Parts analyst commentary  »

Advance Auto Parts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$58.67

-0.05 (-0.09%)

06:58
11/14/18
11/14
06:58
11/14/18
06:58
Periodicals
Verizon aims to widen 5G home broadband offering, Reuters reports »

Verizon is looking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 26

    Nov

W

Wayfair

$92.66

0.97 (1.06%)

06:56
11/14/18
11/14
06:56
11/14/18
06:56
Syndicate
Breaking Syndicate news story on Wayfair »

Wayfair files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

KALA

Kala Pharmaceuticals

$6.56

0.09 (1.39%)

06:55
11/14/18
11/14
06:55
11/14/18
06:55
Recommendations
Kala Pharmaceuticals analyst commentary  »

Kala Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

OI

Owens-Illinois

$16.76

0.55 (3.39%)

06:52
11/14/18
11/14
06:52
11/14/18
06:52
Hot Stocks
Owens-Illinois initiates dividend of 5c, raises share repurchase to $600M »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PENN

Penn National

$19.76

-0.3 (-1.50%)

06:52
11/14/18
11/14
06:52
11/14/18
06:52
Recommendations
Penn National analyst commentary  »

Penn National added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$16.82

-0.08 (-0.47%)

06:51
11/14/18
11/14
06:51
11/14/18
06:51
Earnings
Meritor sees FY19 adj. EPS about $3.10, consensus $3.32 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 06

    Dec

  • 13

    Dec

LLY

Eli Lilly

$111.85

-0.77 (-0.68%)

06:51
11/14/18
11/14
06:51
11/14/18
06:51
Hot Stocks
Eli Lilly submits NDA for lasmiditan, gets breakthrough designation for Emgality »

Eli Lilly has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

06:50
11/14/18
11/14
06:50
11/14/18
06:50
General news
European stock markets pared some of their losses »

European stock markets…

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Earnings
Canada Goose raises FY19 adj. EPS growth view to at least 25% from at least 40% »

Consensus for FY19 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SGMO

Sangamo

$10.80

0.8 (8.00%)

, BMRN

BioMarin

$93.51

0.43 (0.46%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Downgrade
Sangamo, BioMarin, Spark Therapeutics rating change  »

JPMorgan downgrades…

SGMO

Sangamo

$10.80

0.8 (8.00%)

BMRN

BioMarin

$93.51

0.43 (0.46%)

ONCE

Spark Therapeutics

$42.74

1.12 (2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

MTOR

Meritor

$16.82

-0.08 (-0.47%)

06:49
11/14/18
11/14
06:49
11/14/18
06:49
Earnings
Meritor reports Q4 adj. EPS 82c, consensus 71c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 06

    Dec

  • 13

    Dec

MRK

Merck

$74.62

-0.06 (-0.08%)

06:48
11/14/18
11/14
06:48
11/14/18
06:48
Hot Stocks
Merck: Phase 3 KEYNOTE-181 trial met a primary endpoint of overall survival »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 11

    Jan

  • 16

    Feb

WFC

Wells Fargo

$52.74

0.38 (0.73%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Periodicals
Departure of top Wells Fargo exec Hardison shows rift with regulator, WSJ says »

Hope Hardison, Wells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

TRU

TransUnion

$64.43

-0.41 (-0.63%)

06:47
11/14/18
11/14
06:47
11/14/18
06:47
Hot Stocks
TransUnion CEO James Peck to retire, Chris Cartwright to succeed »

TransUnion announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$58.60

1.51 (2.64%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Earnings
Canada Goose reports Q2 adjusted EPS 46c, consensus (7c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

K

Kellogg

$63.48

-0.81 (-1.26%)

, GIS

General Mills

$45.50

-0.2 (-0.44%)

06:46
11/14/18
11/14
06:46
11/14/18
06:46
Downgrade
Kellogg, General Mills, Kraft Heinz rating change  »

JPMorgan downgrades…

K

Kellogg

$63.48

-0.81 (-1.26%)

GIS

General Mills

$45.50

-0.2 (-0.44%)

KHC

Kraft Heinz

$53.38

-0.29 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

06:45
11/14/18
11/14
06:45
11/14/18
06:45
General news
Breaking General news story  »

Week of 11/9 MBA Mortgage…

JNCE

Jounce Therapeutics

$4.40

-0.06 (-1.35%)

06:40
11/14/18
11/14
06:40
11/14/18
06:40
Downgrade
Jounce Therapeutics rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Periodicals
Amazon says over 10,000 workers are developing Alexa, Echo, WSJ reports »

Amazon has over 10,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

NOVN

Novan

$2.50

-0.04 (-1.57%)

06:38
11/14/18
11/14
06:38
11/14/18
06:38
Hot Stocks
Novan Phase 2 molluscum contagiosum trial achieves statistical significance »

Novan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

LLESY

Lendlease Group

$0.00

(0.00%)

06:37
11/14/18
11/14
06:37
11/14/18
06:37
Upgrade
Lendlease Group rating change  »

Lendlease Group upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.